Article info
Research ethics
Paper
Assessing risk/benefit for trials using preclinical evidence: a proposal
- Correspondence to Dr Jonathan Kimmelman, STREAM (Studies of Translation, Ethics and Medicine), Biomedical Ethics Unit, McGill University, Montreal, Quebec, Canada H3A 1X1; jonathan.kimmelman{at}mcgill.ca
Citation
Assessing risk/benefit for trials using preclinical evidence: a proposal
Publication history
- Received May 1, 2015
- Revised August 14, 2015
- Accepted September 20, 2015
- First published October 13, 2015.
Online issue publication
April 27, 2016
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/